Similar articles

• [Other strategies to reduce the use of blood and blood products].

  Martín Vega C. Martín Vega C. Sangre (Barc). 1998 Aug;43(4):339-41. Sangre (Barc). 1998. PMID: 9790002 Review. Spanish. No abstract available.
• Heparin and protamine therapy.

  Arén C. Arén C. Semin Thorac Cardiovasc Surg. 1990 Oct;2(4):364-72. Semin Thorac Cardiovasc Surg. 1990. PMID: 2091796 Review. No abstract available.
• Pharmacologic management of coagulopathy in cardiac surgery: an update.

  Rozental T, Shore-Lesserson L. Rozental T, et al. J Cardiothorac Vasc Anesth. 2012 Aug;26(4):669-79. doi: 10.1053/j.jvca.2012.03.030. Epub 2012 May 17. J Cardiothorac Vasc Anesth. 2012. PMID: 22608465 Review. No abstract available.
• [Hemostatic changes in extracorporeal surgery: pathogenesis and treatment].

  Páramo JA, Rifón J, Rocha E. Páramo JA, et al. Sangre (Barc). 1993 Jun;38(3):225-31. Sangre (Barc). 1993. PMID: 8211549 Review. Spanish. No abstract available.
• Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass.

  DelRossi AJ, Cernaianu AC, Vertrees RA, Wacker CJ, Fuller SJ, Cilley JH Jr, Baldino WA. DelRossi AJ, et al. J Thorac Cardiovasc Surg. 1990 Aug;100(2):281-6. J Thorac Cardiovasc Surg. 1990. PMID: 2385125 Clinical Trial.